ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$MDGL:NASDAQ · MADRIGAL PHARMACEUTICALS INC

Sector: health

Conviction from: NASDAQ

52-week range: 353.54615.00

Madrigal Pharmaceuticals is a biopharmaceutical company that develops and commercializes therapies for liver and metabolic diseases, including its treatment for nonalcoholic steatohepatitis (NASH/MASH).

4 tracked filer(s) hold this · 2 opened, 1 added, 1 trimmed in 30-SEP-2026

Aggregate 13FScore 61 — mean of 4 scored holder(s) · buyers (new/add) avg 56. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Bridgewater55New buy53,627$27,025,8630.1%
Louis Bacon / Moore52New buy5,561$2,802,5220.1%
Paul Tudor Jones / Tudor61Added +24%14,300$7,206,6280.0%
Steve Cohen / Point7275Trimmed -98%3,400$1,713,4640.0%

Beyond 13F — activists, insiders, politicians & research

Insider open-market buys daily digest →

FiledInsiderRoleSharesValue
2026-11-06BAKER BROS. ADVISORS LPdirector91,806$35,023,032Form 4

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.